The Role of FSH in Prostate Cancer: A Case Report.

Castrate Resistant Prostate Cancer (CRPC) is a difficult entity to treat in the spectrum of prostate cancer disease. Recently, Follicle Stimulating Hormone (FSH) has been shown to play an important part in the natural history of prostate cancer disease progression (Crawford et al. , 2014). Here, we discuss a now deceased 94 year-old patient who illustrates the importance of this.

Urology case reports. 2016 Apr 24*** epublish ***

Salvatore Catarinicchia, E David Crawford

University of Colorado, Division of Urology, 12631 E. 17th Avenue, C-305, Aurora, CO 80045, USA., University of Colorado, Division of Urology, 12631 E. 17th Avenue, C-305, Aurora, CO 80045, USA.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe